Related Experiment Videos
Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes?
J D Trudeau1, J P Dutz, E Arany
1Diabetes Research Laboratory, School of Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada.
Diabetes
|January 1, 2000
Summary
Neonatal rodents show increased beta-cell apoptosis, a normal developmental process. This apoptosis wave may trigger autoimmune diabetes by exposing self-antigens and activating immune cells.
Area of Science:
- Developmental biology
- Immunology
- Endocrinology
Background:
- Neonatal rodents exhibit a remodeling phase of beta-cell mass, including apoptosis.
- Beta-cell apoptosis is significantly higher in neonates than adults, peaking around 2 weeks.
- This neonatal apoptosis wave is also observed in autoimmune diabetes models like BB rats and NOD mice.
Purpose of the Study:
- To investigate the role of neonatal beta-cell apoptosis in the initiation of autoimmunity.
- To determine if physiological apoptosis can trigger autoimmune responses.
Main Methods:
- Mathematical modeling to quantify apoptosis rates.
- Histochemical detection methods for beta-cell apoptosis.
- Analysis of animal models of autoimmune diabetes (BB rat, NOD mouse).
Main Results:
- Beta-cell apoptosis is significantly increased in neonatal rodents compared to adults.
- This increased apoptosis is present in autoimmune diabetes models.
- Apoptotic cells can display autoantigens and activate immune cells, potentially initiating autoimmunity.
- Autoimmunity initiation in models appears fixed around 15 days of age.
Conclusions:
- The neonatal wave of beta-cell apoptosis is hypothesized to be a trigger for beta-cell-directed autoimmunity.
- Physiological apoptosis, under certain conditions, may initiate autoimmune responses.
- Understanding this mechanism is crucial for developing strategies to prevent autoimmune diabetes.